Approved indications: In adults, valacyclovir treats cold sores (herpes labialis), genital herpes (initial and recurrent episodes), provides suppressive therapy for recurrent genital herpes in immunocompetent and certain HIV-1–infected patients, reduces genital herpes transmission in immunocompetent adults, and treats shingles (herpes zoster); in immunocompetent children, it treats cold sores (≥12 years) and chickenpox (ages 2 to <18 years).

Off-label uses (evidence level generally moderate to strong but not FDA-approved):

• Prevention of recurrent herpes labialis or genital herpes in people with very frequent outbreaks when labeled suppressive regimens are adapted to other HSV sites.
• Peri-pregnancy use (late third trimester) to suppress genital herpes and lower the risk of active lesions at delivery, typically guided by obstetric and infectious disease guidelines.
• Prevention or treatment of HSV or varicella-zoster reactivations in some immunocompromised or transplant patients where clinicians individualize dosing based on protocols.

Efficacy expectations and timing: When started early in an outbreak (often within 24–72 hours of symptom onset), valacyclovir usually shortens the time to crusting and healing of cold sores, genital lesions, or shingles by about 1–2 days and reduces pain intensity and viral shedding; with daily suppressive therapy, many patients experience far fewer genital herpes recurrences (often a reduction of ≥70%) and reduced transmission risk to partners when combined with safer-sex practices. Its overall effectiveness is comparable to acyclovir and famciclovir, but valacyclovir is often preferred for its more convenient dosing and similar or better clinical outcomes.

How to take it: Swallow tablets whole with a glass of water, with or without food, at evenly spaced times; if you are prescribed a liquid suspension, shake it well before each dose and use a marked oral syringe or dosing spoon rather than a kitchen spoon.

Typical adult oral doses (immunocompetent):

• Cold sores: 2 grams every 12 hours for 1 day (two doses total), started at the first sign of tingling, burning, or other prodrome.
• Initial genital herpes episode: 1 gram twice daily for 10 days, ideally started within 48 hours of symptom onset.
• Recurrent genital herpes episode: 500 mg twice daily for 3 days, started at the earliest symptoms.
• Suppressive therapy for recurrent genital herpes: 1 gram once daily, or 500 mg once daily in some patients with ≤9 recurrences per year.
• Reduction of genital herpes transmission: 500 mg once daily in immunocompetent adults with a history of genital herpes.
• Shingles (herpes zoster): 1 gram three times daily for 7 days, best started within 72 hours of rash onset.

Typical pediatric oral doses (immunocompetent):

• Cold sores (≥12 years): 2 grams every 12 hours for 1 day, the same regimen as for adults.
• Chickenpox (ages 2 to <18 years): 20 mg/kg by mouth three times daily for 5 days (up to a maximum of 1 gram three times daily), typically started within 24 hours after rash begins.

Special dosing instructions: People with reduced kidney function, older adults, and certain immunocompromised patients usually need lower or less frequent doses as determined by their clinician, and all patients should maintain good hydration (drink plenty of fluids) while taking valacyclovir.

Missed dose: If you miss a dose, take it as soon as you remember unless it is almost time for your next scheduled dose; if it is close to the next dose, skip the missed dose and resume your regular schedule, and do not double up doses.

Overdose: Taking more than prescribed can increase the risk of serious kidney and neurologic problems; if an overdose is suspected, contact poison control or emergency medical services immediately, even if you feel well.

Common side effects:

• Headache, nausea, and stomach (abdominal) pain are the most frequently reported effects in adults, and headache is most common in children; these are usually mild to moderate and often improve as your body adjusts.
• Other less common effects can include tiredness, dizziness, vomiting, or mild rash; these typically occur within the first few days of treatment and often resolve without needing to stop the medicine.

Serious or rare adverse effects (seek urgent care):

• Allergic reactions such as swelling of the face or throat, trouble breathing, or severe rash or hives.
• Kidney problems, including decreased urine, blood in the urine, or sudden weight gain and swelling, especially in people with preexisting kidney disease, older adults, those who are dehydrated, or those taking other kidney-affecting drugs.
• Neurologic symptoms such as confusion, agitation, hallucinations, extreme drowsiness, tremors, or seizures, which are more likely at very high doses or with kidney impairment.
• Very rare blood disorders such as thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS), mainly reported in severely immunocompromised or transplant patients on high doses, presenting with unexplained bruising, anemia, or decreased urination.

Warnings and precautions: Dose reductions are often needed in people with reduced kidney function, and older adults should be monitored more closely for kidney and neurologic side effects; use during pregnancy or breastfeeding is generally considered acceptable when clearly needed, but decisions should be individualized with an obstetric or pediatric provider. Safety and dosing are not established for some ages and conditions (such as genital herpes or shingles in younger children), and valacyclovir is used cautiously or with specialist input in severely immunocompromised patients.

Comparative safety: Overall, valacyclovir has a safety profile similar to acyclovir and famciclovir, and it is usually well tolerated when dosed correctly, with serious toxicity uncommon outside of overdose, severe kidney impairment, or intensive high-dose regimens in very ill patients.

Reporting side effects and staying informed: Patients can report suspected side effects to their healthcare provider and to the FDA MedWatch program (online or by phone), and they can check the FDA or manufacturer websites or updated patient information leaflets for the latest safety communications.

Drug and supplement interactions:

• Medicines that affect the kidneys (such as certain NSAIDs, IV contrast dyes, aminoglycoside antibiotics, cyclosporine, tacrolimus, and some chemotherapy agents) can increase the risk of kidney injury when combined with valacyclovir, so your provider may adjust doses and monitor kidney function.
• Cimetidine and probenecid can raise blood levels of acyclovir (the active form of valacyclovir) by reducing its kidney excretion; this usually has limited impact in people with normal kidneys but may matter at high doses or in those with kidney impairment.
• Valacyclovir has few significant interactions with most common prescription drugs via liver enzymes, and it has no specific known interactions with typical foods; it can be taken with or without meals.

Alcohol and herbal products: There is no direct interaction with moderate alcohol use, but heavy drinking can promote dehydration and strain the kidneys, so it is wise to limit alcohol and stay well hydrated; most standard vitamins are compatible, but you should review herbal or high-dose supplements (such as high-dose creatine or unknown “immune boosters”) with your clinician.

Key precautions and situations needing extra care:

• Preexisting kidney disease, advanced age, or conditions that cause dehydration (vomiting, diarrhea, poor fluid intake).
• History of TTP/HUS, bone marrow or solid-organ transplant, or advanced HIV infection, particularly if high doses are planned.
• Pregnancy and breastfeeding, where benefits and potential risks should be weighed and dosing individualized.
• Use in children outside labeled age ranges or in severely immunocompromised children, which should be guided by a specialist.

Monitoring needs: For patients on high doses, long-term suppressive therapy, or those with kidney or other serious health problems, clinicians often monitor kidney function with blood tests (creatinine, BUN) and may watch for neurologic symptoms, unusual bruising, or changes in blood counts depending on overall risk.

Q: Does valacyclovir cure herpes or just control it?
A: Valacyclovir does not remove herpes viruses from your body, but it shortens and eases outbreaks and, when taken daily, can greatly reduce how often they occur and how likely you are to pass genital herpes to a partner.

Q: How fast will valacyclovir start working on a cold sore or genital outbreak?
A: If you start it at the very first warning signs (tingling, burning, or early redness), many people notice less pain within 1–2 days and sores that heal about 1–2 days sooner than without treatment.

Q: Is it safe to take valacyclovir every day for prevention?
A: Many adults safely use daily suppressive valacyclovir for months or years under medical supervision, with periodic check-ins—especially for kidney function and side effects—to be sure the dose remains appropriate.

Q: Can I drink alcohol while taking valacyclovir?
A: Moderate alcohol use is generally acceptable for most people on valacyclovir, but you should avoid heavy drinking, stay well hydrated, and follow any specific advice from your clinician based on your liver and kidney health.

Q: Is valacyclovir safe during pregnancy or breastfeeding?
A: Experience suggests valacyclovir is relatively low risk when needed in pregnancy or while breastfeeding, and it is commonly used for genital herpes management, but decisions should always be made with your obstetric or pediatric provider.

Q: What should I do if I keep getting outbreaks even while on valacyclovir?
A: Let your clinician know, as they may check your dosing and kidney function, look for triggers such as stress or other illnesses, adjust your regimen, or consider testing to rule out other skin or immune conditions.

Storage: Store tablets at room temperature (59°F to 77°F / 15°C to 25°C) in a tightly closed container, away from moisture, heat, and light, and out of reach of children; if you are given a liquid suspension, keep it refrigerated as labeled and discard any unused suspension after the time your pharmacist specifies (often 28 days).

Disposal: Do not flush unused tablets or suspension down the toilet; instead, use a local medicine take-back program when available or, if none is accessible, mix unwanted medicine with something unappealing (such as used coffee grounds or cat litter), seal it in a sturdy container or bag, and place it in household trash according to pharmacist or local guidance.